News | May 31, 2023
Synexa Joins CEPI in advancing global epidemic preparedness and response
Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness
Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness
Two patents were filed during the quarter ended 31st March, 2023 and the cumulative filings till date are 3239
India’s efforts are aimed at boosting health at the last mile
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
The need is to focus on an enabling framework to bridge the digital divide across countries specifically amongst low-and-middle-income countries
Nous-209 has been developed using the Nouscom's viral vector platform
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Biocon Biologics Limited will have access to 100 million doses of vaccines annually together with the distribution rights to Serum's Vaccine portfolio
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
Subscribe To Our Newsletter & Stay Updated
